24 search results for: disease background

Digestive <b>Disease</b> Week 2024 | Washington D.C.
Awareness Day
18
May
2024
Awareness Day
Digestive Disease Week 2024 | Washington D.C.

Join ADVENT at the Digestive Disease Week 2024 Congress and visit the Sanofi and Regeneron Medical Booth # 1707.

ADVENT at IRS-ISIAN | Evolving Perspectives in CRSwNP: From Symptom Control to <b>Disease</b> Remission
Congress
5
April
2024
Congress
ADVENT at IRS-ISIAN | Evolving Perspectives in CRSwNP: From Symptom Control to Disease Remission

Join Profs. Shigeharu Fujieda, Peter Hellings, and Eugenio De Corso for an educational symposium on the evolving understanding of disease control and clinical remission in CRSwNP.

ADVENT at ESPGHAN | Shedding Light on Pediatric Eosinophilic Esophagitis: Timely Identification and Management
Congress
17
May
2024
Congress
ADVENT at ESPGHAN | Shedding Light on Pediatric Eosinophilic Esophagitis: Timely Identification and Management

Join global experts Prof. Salvatore Oliva and Dr. Dhandapani Ashok for an educational symposium at ESPGHAN, as they discuss the burden and impact of underlying type 2 inflammation in eosinophilic esophagitis (EoE), and the importance of early diagnosis and management in pediatric patients.

Exploring the Potential <b>Disease</b>-Modifying Approaches in AD
Dermatology
Exploring the Potential Disease-Modifying Approaches in AD
interactivity

Explore the concept of disease modification in atopic dermatitis through this interactive infographic, which highlights potential considerations such as optimal sustained disease control, subclinical inflammation, the pathophysiology of AD, and atopic/non-atopic comorbidities.

View more
Distinct Mechanisms Drive Inflammation and Itch in Chronic, Type 2 Inflammatory <b>Disease</b>s
Type 2 Inflammation
Distinct Mechanisms Drive Inflammation and Itch in Chronic, Type 2 Inflammatory Diseases
expert video

In this soundbite video from the April 2025 ADVENT Forum in Lisbon, Portugal, Dr Brian Kim provides an overview of itch in type 2 inflammatory skin diseases and explains how the shared and unique mechanisms that drive inflammation and itch mediate each disease in distinct ways.

View more
Both Clinical and Subclinical <b>Disease</b> Control Are Important to Achieve <b>Disease</b> Modification in AD
Dermatology
Both Clinical and Subclinical Disease Control Are Important to Achieve Disease Modification in AD
expert video

In this soundbite video from the April 2025 ADVENT Forum in Lisbon, Portugal, Dr. Eric Simpson explains how both clinical and subclinical disease control are critical for achieving true disease modification in atopic dermatitis, emphasizing the role of biomarkers in predicting long-term outcomes and guiding treatment decisions.

View more
Atopic Dermatitis and the Risk of Developing Other Atopic <b>Disease</b>s
Dermatology
Atopic Dermatitis and the Risk of Developing Other Atopic Diseases
expert video

In this soundbite video from the April 2025 ADVENT Forum in Lisbon, Portugal, Dr Amy Paller discusses the significant risk of developing other atopic diseases among infants with early-onset atopic dermatitis.

View more
Can Therapy-Free <b>Disease</b> Control Be Achieved in Atopic Dermatitis?
Dermatology
Can Therapy-Free Disease Control Be Achieved in Atopic Dermatitis?
expert video

In this soundbite video from the April 2025 ADVENT Forum in Lisbon, Portugal, Prof. Thomas Bieber discusses emerging evidence that therapy-free disease control may be possible in atopic dermatitis, citing pediatric dupilumab data showing that a subset of patients-maintained remission after treatment discontinuation.

View more
Digging Deeper: Reducing Non-Atopic Comorbidities and Multidimensional <b>Disease</b> Burden
Dermatology
Digging Deeper: Reducing Non-Atopic Comorbidities and Multidimensional Disease Burden
expert video

In this clip from the April WCPD 2025 symposium, Dr Paula Luna discusses how moderate-to-severe AD may hinder growth in pediatric patients.

View more
CLCI in Atopic Dermatitis Infographic
Dermatology
CLCI in Atopic Dermatitis Infographic
Infographic

This infographic highlights how uncontrolled moderate‑to‑severe atopic dermatitis (AD) can lead to Cumulative Life Course Impairment (CLCI) by contributing to ongoing physical, psychological, and social burdens such as itch and sleep loss, impaired bone growth and mental health challenges. It emphasizes the importance of early and effective disease control to help reduce long‑term impact on patients.

View more
ADVENT Forum 2025 On Demand page
On Demand
ADVENT Forum 2025 On Demand page

Watch on-demand expert soundbites recorded at the April 2025 ADVENT Forum in Lisbon, Portugal, featuring dermatology and immunology perspectives on mechanisms and clinical practice. Topics range from disease mechanism to patient care and quality of life, spanning atopic dermatitis (AD), prurigo nodularis (PN), chronic spontaneous urticaria (CSU) and bullous pemphigoid (BP).

CSU is Unpredictable in its Course and Duration
Dermatology
CSU is Unpredictable in its Course and Duration
expert video

Dr. Hawkes highlights how Chronic Urticaria is a mast cell centric disease with moderate levels of spontaneous remission in patients.

View more